Profile
Agent Capital is a healthcare venture capital firm based in Boston. Founded by Dr. Geeta Vemuri and Dr. Preston Noon, the firm emphasizes building transformative healthcare solutions that address unmet medical needs. Their core team, consisting of experts in biopharma and life sciences, leverages a deep understanding of industry pressures and trends, setting them apart in their investment approach. The founders bring significant experience from their past roles at Baxter Ventures, Baxalta Ventures, and other key positions within the pharmaceutical industry.
Agent Capital primarily invests in therapeutics at various stages of development, ranging from preclinical to commercial phases. They focus on areas such as rare diseases, oncology, neurology, and immunology. The firm does not confine itself to any specific geographical boundaries. While exact AUM details are not specified, Agent Capital's impact on the advancement of healthcare treatments is evident in their strategic partnerships.
Notable investments include Dice Therapeutics, Freenome, Metagenomi, Pliant Therapeutics, and Skyhawk Therapeutics. The firm is consistently recognized for its contribution to the biopharma sector by backing science-driven innovations that have transformative potential. These investments showcase their commitment to pioneering therapies that shape the future of patient care.
Industry
Agent Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Agent Capital Fund I
|
Venture Capital (VC)
|
Healthcare Services
AI
Technology
Life Sciences
|
Seed
Series A
Series B
|
North America
|
$5-10 m
|
$63 M
|
June 2017
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.